ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Louisiana » Endocrinology, Diabetes Metabolism

Top Endocrinology, Diabetes Metabolism Prescribers in Louisiana

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ESCIPION PEDROZA M.D.

Endocrinology, Diabetes Metabolism

19,226

$1.59M

913
711 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 44%

$82
Average prescription price

Avg: $104

HANNA LUBBOS MD

Endocrinology, Diabetes Metabolism

15,343

$1.01M

512
362 are 65+

11%
patients receiving schedule two controlled substances

Avg: 0%

16%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 44%

$66
Average prescription price

Avg: $104

MIGUEL RIVERA M.D.

Endocrinology, Diabetes Metabolism

11,900

$971K

655
496 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

9%
patients receiving schedule three controlled substances

Avg: 2%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 44%

$82
Average prescription price

Avg: $104

JOEL SILVERBERG MD

Endocrinology, Diabetes Metabolism

10,641

$824K

688
537 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 44%

$77
Average prescription price

Avg: $104

GHYASS RIZK MD

Endocrinology, Diabetes Metabolism

8,451

$622K

470
356 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 44%

$74
Average prescription price

Avg: $104

HAROLD MILLER M.D.

Endocrinology, Diabetes Metabolism

8,282

$1.08M

660
438 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

48%
prescriptions for brand name drugs

Avg: 44%

$130
Average prescription price

Avg: $104

JOSEPH MURRAY M.D.

Endocrinology, Diabetes Metabolism

7,902

$712K

517
436 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 44%

$90
Average prescription price

Avg: $104

TUAN-HUY TRAN MD

Endocrinology, Diabetes Metabolism

7,621

$1.04M

674
503 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

50%
prescriptions for brand name drugs

Avg: 44%

$137
Average prescription price

Avg: $104

JONATHAN WISE MD

Endocrinology, Diabetes Metabolism

7,414

$876K

760
591 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 44%

$118
Average prescription price

Avg: $104

DAVID SISAM DO

Endocrinology, Diabetes Metabolism

6,822

$552K

508
397 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 2%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 44%

$81
Average prescription price

Avg: $104

BENNETT BAQUET M.D.

Endocrinology, Diabetes Metabolism

6,334

$754K

630
441 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

52%
prescriptions for brand name drugs

Avg: 44%

$119
Average prescription price

Avg: $104

GARY FIELD MD

Endocrinology, Diabetes Metabolism

5,869

$496K

423
320 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 2%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

49%
prescriptions for brand name drugs

Avg: 44%

$84
Average prescription price

Avg: $104

JUSTIN FONTENOT MD

Endocrinology, Diabetes Metabolism

4,917

$583K

386
276 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

49%
prescriptions for brand name drugs

Avg: 44%

$119
Average prescription price

Avg: $104

ALAN BURSHELL MD

Endocrinology, Diabetes Metabolism

4,627

$480K

498
374 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 44%

$104
Average prescription price

Avg: $104

UMA RANGARAJ MD

Endocrinology, Diabetes Metabolism

4,464

$480K

451
323 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 44%

$108
Average prescription price

Avg: $104

RAMONA GRANDA-RODRIGUEZ MD

Endocrinology, Diabetes Metabolism

4,345

$453K

310
235 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

46%
prescriptions for brand name drugs

Avg: 44%

$104
Average prescription price

Avg: $104

TRUDY SANSON M.D.

Endocrinology, Diabetes Metabolism

4,127

$151K

509
404 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 44%

$37
Average prescription price

Avg: $104

SAMUEL ANDREWS MD

Endocrinology, Diabetes Metabolism

3,980

$475K

363
282 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 44%

$119
Average prescription price

Avg: $104

MARIDELI SCANLAN MD

Endocrinology, Diabetes Metabolism

3,950

$623K

368
277 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

58%
prescriptions for brand name drugs

Avg: 44%

$158
Average prescription price

Avg: $104

MADELYN WIEGAND MD

Endocrinology, Diabetes Metabolism

3,719

$420K

288
217 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

60%
prescriptions for brand name drugs

Avg: 44%

$113
Average prescription price

Avg: $104

MONISHA CHADHA MD

Endocrinology, Diabetes Metabolism

3,199

$415K

320
147 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

39%
prescriptions for brand name drugs

Avg: 44%

$130
Average prescription price

Avg: $104

LAURA KIMBALL-RAVARI MD

Endocrinology, Diabetes Metabolism

3,177

$439K

355
256 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

58%
prescriptions for brand name drugs

Avg: 44%

$138
Average prescription price

Avg: $104

JEANNEMARIE HINKLE MD

Endocrinology, Diabetes Metabolism

3,079

$365K

306
233 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

48%
prescriptions for brand name drugs

Avg: 44%

$119
Average prescription price

Avg: $104

HAYTHAM KAWJI MD

Endocrinology, Diabetes Metabolism

2,909

$444K

249
154 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

52%
prescriptions for brand name drugs

Avg: 44%

$152
Average prescription price

Avg: $104

TIMOTHY GILBERT M.D.

Endocrinology, Diabetes Metabolism

2,509

$305K

291
207 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

53%
prescriptions for brand name drugs

Avg: 44%

$121
Average prescription price

Avg: $104

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank